The aim of this Research Training Program is to recruit and prepare highly qualified physician/scientists for an academic research career in medical or gynecological oncology by developing research skills in cancer biology and therapy. The general areas of training include: 1) Clinical Hematopoietic Cell Transplantation;2) Immunology and Vaccine Development;3) Transplantation Biology;4) Stem/Progenitor Cell Biology;5) Women's Cancer Research;6) Genito-urinary Cancer Research;7) Gastro-intestinal Cancer Research;8) Human Biology. All trainees will be members of the Hematology/Oncology or Gynecologic Oncology Fellowship Programs of the University of Washington/Fred Hutchinson Cancer Research Center. Trainees receive specific didactic training in the fundamentals of oncology research, including biostatistics, protocol development, data analysis, medical and research ethics, use and care of animals in research and use of human subjects in research. The majority of the trainee's time is spent conducting research under the direct supervision of a faculty mentor selected by the trainee with additional guidance from the Fellowship Training Program Committee.

Public Health Relevance

In 2009, approximately 1.48 million individuals in the United States will be diagnosed with cancer and 563,000 will die of the disease. Clearly, new approaches to cancer prevention, diagnosis and treatment are needed, and these will only come from new insights achieved through research. This Research Training Program is designed to directly respond to this need by recruiting and training exceptionally qualified physician scientists for a career in cancer research.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
5T32CA009515-29
Application #
8517441
Study Section
Subcommittee G - Education (NCI)
Program Officer
Lim, Susan E
Project Start
1985-07-01
Project End
2015-06-30
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
29
Fiscal Year
2013
Total Cost
$638,503
Indirect Cost
$47,738
Name
University of Washington
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Mostaghel, Elahe A; Martin, Paul S; Mongovin, Stephen et al. (2017) Androgen receptor expression in mantle cell lymphoma: Potential novel therapeutic implications. Exp Hematol 49:34-38.e2
Alva, Ajjai; Nordquist, Luke; Daignault, Stephanie et al. (2017) Clinical Correlates of Benefit From Radium-223 Therapy in Metastatic Castration Resistant Prostate Cancer. Prostate 77:479-488
Ramos, Jorge D; Casey, Martin F; Bamias, Aristotelis et al. (2017) The Khorana Score in Predicting Venous Thromboembolism for Patients With Metastatic Urothelial Carcinoma and Variant Histology Treated With Chemotherapy. Clin Appl Thromb Hemost 23:755-760
Cowan, Andrew J; Stevenson, Phillip A; Gooley, Ted A et al. (2017) Results of a phase I-II study of fenretinide and rituximab for patients with indolent B-cell lymphoma and mantle cell lymphoma. Br J Haematol 176:583-590
Ramos, Jorge D; Wingate, Jonathan T; Gulati, Roman et al. (2017) Venous Thromboembolism Risk in Patients With Locoregional Urothelial Tract Tumors. Clin Genitourin Cancer :
Kirtane, Kedar; Lee, Stephanie J (2017) Racial and ethnic disparities in hematologic malignancies. Blood 130:1699-1705
Ramos, Jorge D; Casey, Martin F; Crabb, Simon J et al. (2017) Venous thromboembolism in metastatic urothelial carcinoma or variant histologies: incidence, associative factors, and effect on survival. Cancer Med 6:186-194
Yan, Fengting; Gopal, Ajay K; Graf, Solomon A (2017) Targeted Drugs as Maintenance Therapy after Autologous Stem Cell Transplantation in Patients with Mantle Cell Lymphoma. Pharmaceuticals (Basel) 10:
Paulson, Kelly G; Lewis, Christopher W; Redman, Mary W et al. (2017) Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: A prospective validation study. Cancer 123:1464-1474
Senapati, Suneeta; Sammel, Mary D; Morse, Christopher et al. (2016) Impact of endometriosis on in vitro fertilization outcomes: an evaluation of the Society for Assisted Reproductive Technologies Database. Fertil Steril 106:164-171.e1

Showing the most recent 10 out of 221 publications